Tissue-specific, non-invasive toxicity biomarkers: translation from preclinical safety assessment to clinical safety monitoring. [electronic resource]
- Expert opinion on drug metabolism & toxicology Sep 2009
- 1023-38 p. digital
Publication Type: Journal Article; Review
1744-7607
10.1517/17425250903114174 doi
Animals Biomarkers--blood Clinical Trials as Topic--methods Drug Approval Drug Evaluation, Preclinical--methods Drug-Related Side Effects and Adverse Reactions--blood Humans